Japan Tissue Engineering Co., Ltd. (TYO:7774)
637.00
-11.00 (-1.70%)
Nov 18, 2026, 10:20 AM JST
Japan Tissue Engineering Market Cap
Japan Tissue Engineering has a market cap or net worth of 25.87 billion as of November 17, 2026. It is the 21,450th most valuable company in the world and the 1,721st biggest in Japan. Its market cap has increased by 33.26% in one year.
Market Cap
25.87B
Enterprise Value
22.54B
Revenue
2.68B
Global Rank
Country Rank
#1,721 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 21, 2007, Japan Tissue Engineering's market cap has increased from 5.99B to 25.87B, an increase of 331.69%. That is a compound annual growth rate of 8.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 25.87B | 2.41% |
| Dec 30, 2025 | 25.26B | 34.34% |
| Dec 30, 2024 | 18.80B | -8.50% |
| Dec 29, 2023 | 20.55B | 8.35% |
| Dec 30, 2022 | 18.96B | -17.49% |
| Dec 30, 2021 | 22.99B | -8.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Heartseed | 66.05B |
| SanBio Company | 65.73B |
| Cuorips | 58.79B |
| 3-D Matrix | 40.83B |
| Healios K.K. | 30.90B |
| Innovacell | 22.58B |
| RaQualia Pharma | 16.82B |
| CanBas | 13.94B |